share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

Arcutis Biotherapeutics | 4：持股變動聲明-高管 Burnett Patrick
美股SEC公告 ·  11/19 08:10

Moomoo AI 已提取核心訊息

Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a series of stock transactions between November 14, 2024, and November 15, 2024. Burnett engaged in both the acquisition and disposal of common stock shares. On November 14, Burnett acquired 18,377 shares at no cost, an action described as the exercise or conversion of derivative security. On the same day, Burnett sold 50,749 shares at a price of $10.2945 per share, followed by the sale of 18,377 shares at the same price, both transactions classified as open market or private sales. The following day, Burnett acquired 100 shares, again at no cost, and sold the same number of shares at $10.03 each. After these transactions, Burnett held a total of 128,669 shares of Arcutis Biotherapeutics. The total value of the disposed shares amounted to approximately $712,620.61.
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a series of stock transactions between November 14, 2024, and November 15, 2024. Burnett engaged in both the acquisition and disposal of common stock shares. On November 14, Burnett acquired 18,377 shares at no cost, an action described as the exercise or conversion of derivative security. On the same day, Burnett sold 50,749 shares at a price of $10.2945 per share, followed by the sale of 18,377 shares at the same price, both transactions classified as open market or private sales. The following day, Burnett acquired 100 shares, again at no cost, and sold the same number of shares at $10.03 each. After these transactions, Burnett held a total of 128,669 shares of Arcutis Biotherapeutics. The total value of the disposed shares amounted to approximately $712,620.61.
與arcutis biotherapeutics有關的Patrick Burnett，於2024年11月14日至2024年11月15日期間完成了一系列股票交易。Burnett參與了普通股股份的收購和處置。11月14日，Burnett以零成本獲得了18,377股股份，這一行動被描述爲衍生安防-半導體的行使或轉換。同一天，Burnett以每股10.2945美元的價格出售了50,749股，隨後以相同價格出售了18,377股，這兩筆交易被歸類爲公開市場或私人銷售。次日，Burnett再次以零成本獲得100股，並以每股10.03美元出售了同樣數量的股份。在這些交易之後，Burnett持有arcutis biotherapeutics共128,669股。處置股份的總價值約爲$712,620.61。
與arcutis biotherapeutics有關的Patrick Burnett，於2024年11月14日至2024年11月15日期間完成了一系列股票交易。Burnett參與了普通股股份的收購和處置。11月14日，Burnett以零成本獲得了18,377股股份，這一行動被描述爲衍生安防-半導體的行使或轉換。同一天，Burnett以每股10.2945美元的價格出售了50,749股，隨後以相同價格出售了18,377股，這兩筆交易被歸類爲公開市場或私人銷售。次日，Burnett再次以零成本獲得100股，並以每股10.03美元出售了同樣數量的股份。在這些交易之後，Burnett持有arcutis biotherapeutics共128,669股。處置股份的總價值約爲$712,620.61。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間